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Sepsis and ensuing multiple organ failure continue to be the most leading cause of death in critically ill patients. Despite hepatocyte-related
dysfunctions such as necrosis, apoptosis as well as mitochondrial damage are observed in the process of sepsis, the molecular mechanism of
pathogenesis remains uncertain. We recently identified one of the differentially expressed genes, mitochondrial ATPase inhibitor protein (IF1)
which is down-regulated in late septic liver. Hence, we further hypothesized that the variation of IF1 protein may be one of the causal events of the
hepatic dysfunction during late sepsis. The results showed that the elevated mitochondrial F0F1-ATPase activity is concomitant with the decline of
intramitochondrial ATP concentration in late septic liver. In addition, the key finding of this study showed that the mRNA and the mitochondrial
content of IF1 were decreased in late sepsis while no detectable IF1 was found in cytoplasm. When analyzed by immunoprecipitation, it seems
reasonable to imply that the association capability of IF1 with F1-ATPase β-subunit is not affected. These results confirm the first evidence showing
that the suppression of IF1 expression and subsequent elevated mitochondrial F0F1-ATPase activity might contribute to the bioenergetic failure in
the liver during late sepsis.
© 2007 Elsevier B.V. All rights reserved.Keywords: Sepsis; Mitochondrial F0F1-ATPase; IF1; Liver1. Introduction
Sepsis is a systemic response to an infection and is still the
most common cause of death in intensive care units (ICUs)
among adults and children [1,2]. In septic patients, severe in-
flammation damages the heart, kidneys, lungs, liver, central
nervous system and coagulation system, leading to multiple
organ dysfunctions. The liver plays a pivotal role in modulating
the systemic response to sepsis because of its central contri-
bution in metabolism and host defense mechanism. It has been
demonstrated that the mortality rate in patients with hepatic
dysfunction is greater than those without [3]. Furthermore, the
sepsis-induced liver dysfunction manifested by disseminated
intravascular coagulation (DIC), reduced hepatic lactate and⁎ Corresponding author. Graduate Institute of Physiology and Molecular
Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807,
Taiwan.
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doi:10.1016/j.bbabio.2007.03.009amino acid clearances, decreased gluconeogenesis, and glyco-
genolysis with subsequent hypoglycemia, is typically consid-
ered to be a complication of late sepsis [4].
Hepatic dysfunction associated with necrosis, apoptosis as
well as mitochondrial damage of hepatocytes were observed
during sepsis [5–7], while the underlying molecular mechanism
remained uncertain. Several lines of evidence indicate that
cellular energy is deranged in sepsis, some by inadequate tissue
perfusion but mostly by impaired mitochondrial respiration [8].
Under aerobic conditions, most of the ATP necessary to supply
organs and tissues is generated by the mitochondrial oxidative
phosphorylation mechanism. Cell functions can continue only
by uninterrupted mitochondrial energy production. Therefore,
dysfunctional mitochondrial respiratory chain reaction can
affect all organs and tissues and cause a wide variety of dis-
orders [9]. Many studies of impaired NADH availability, mito-
chondrial ultrastructure and enzymatic activities of complex I
and IV have been revealed to closely correlate with decreased
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ATP declination is more prominent than that of enzyme
dysfunctions, therefore, it is unable to fully define the low
ATP content during sepsis. In addition, Brealey and colleagues
[12] demonstrated that the hepatic ATP concentrations were
significantly lower in the septic rats together with the concurrent
rise in ADP and AMP, suggesting the presence of increased
ATP hydrolysis.
We recently identified differentially expressed genes (DEGs)
in the late septic liver using a PCR-based suppression sub-
tractive hybridization (SSH) method. Nine DEGs were isolated
and five of them were not reported to be linked to sepsis [13].
Among the 9 DEGs, mitochondrial ATPase inhibitor protein
(IF1) was found to be a novel gene in mitochondrial dysfunction
during sepsis. In rat liver, IF1 is a small protein containing 82
amino acid residues and reacts reversibly with F0F1-ATPase and
inhibits up to 90% of its ATPase activity [14]. Papa et al. have
shown that the synthetic peptide with the Leu 42–Lys 58
sequence is equally effective as IF1 in inhibiting the ATPase
activity of both the F0F1 complex in the membrane and soluble
F1 [15]. Accordingly, we hypothesized that IF1 may be involved
in the hepatic dysfunction during late sepsis. The current study
was designed to evaluate the expression of IF1 and mitochon-
drial F0F1-ATPase activity in the liver of sham-operation and
late sepsis, and its mechanism was discussed.2. Materials and methods
2.1. Induction of septic animals
Male Sprague–Dawley rats weighing 300–350 g were purchased from the
National Experimental Animal Center (Nan-Kang, Taipei, Taiwan) and were
bred in the animal center of Kaohsiung Medical University. Animals were
divided randomly into sham-operation and experimental groups and were fasted
prior to the operation procedure. After the animals were deeply anesthetized
with pentobarbital (60 mg/kg, intraperitoneally), sepsis was induced by cecal
ligation and puncture (CLP) according to the method of Wichterman et al. [16]
with some modification. First of all, a laparotomy was performed and the cecum
was ligated with a 3-0 silk ligature and punctured in two sites with an 18-gauge
needle. The cecum was then returned to the peritoneal cavity, and the abdomen
was closed in two layers. Control rats were sham-operated (a laparotomy was
performed, and the cecum was manipulated but neither ligated nor punctured). It
has been demonstrated that the CLP rats show metabolism disturbances by 9 h
with a hyperglycemic state, and that the hypoglycemic state becomes evident at
18 h [17]. Hence, 18 h after CLP was referred to late sepsis in the present study.
2.2. Isolation of mitochondrial and cytosolic fractions from rat liver
Specimens of liver were quickly excised and washed with ice-cold 0.25 M
sucrose solution. The livers were then minced into small pieces and
homogenized in 10 ml of ice-cold SEH buffer containing 0.25 M sucrose,
0.5 mM EGTA, 3 mM HEPES, pH 7.2 per gram wet weight of liver. To remove
cell debris, the homogenate was then centrifuged at 800×g for 10 min at 4 °C.
The collected supernatant was centrifuged twice at 9500×g for 10 min at 4 °C to
collect both the cytosol (supernatant) and the mitochondrial pellet. This pellet
was washed twice with SEH buffer by repeating the above centrifugations. The
final mitochondrial pellet was resuspended in a minimal amount of SEH buffer.
Usually 6–8 mg of the mitochondria could be obtained from 1 g of rat liver. The
integrity of the isolated mitochondria was checked by transmission electron
microscopy. Mitochondrial protein extraction was obtained by repeated freeze–
thaw of intact mitochondria for 3 times. The protein concentration of the re-
sulting mitochondrial suspension was determined using the dye binding proteinassay (Bio-Rad, Hercules, USA) and bovine serum albumin as the standard. To
check the purity of cytosolic and mitochondrial fractions, Western blot analysis
was performed using antibodies of GAPDH for cytosol and cytochrome
c oxidase subunit IV for mitochondria, as previously described by Ekedahl et al.
and Wiltshire et al. [18,19].
2.3. Preparation of MgATP-submitochondrial particles
(MgATP-SMPs)
The MgATP-SMPs of rat liver was prepared according to Wei [20] with
minor modification. The mitochondria were sonicated in 15 mM MgSO4 and
1 mM ATP, pH 7.5 over ice water. The sonication was carried out at the power
scale of 4 for about 10 min, with intermittent 1- to 2-min intervals of reduced
heating effect. The sonicated particles were centrifuged at 136,000×g for 30 min
at 4 °C by using ultracentrifuge (Hitachi CS120GXL, Tokyo, Japan). The firmly
packed pellet was resuspended in SEH buffer and considered as the MgATP-
SMPs and which should be used within 24 h. Protein concentration of MgATP-
SMPs was determined with the dye binding protein assay (Bio-Rad, Hercules,
USA) and bovine serum albumin as the standard.
2.4. Transmission electron microscopy (TEM)
Mitochondrial ultrastructure was determined to assess purity and integrity of
isolated mitochondria. The final mitochondrial pellets were fixed overnight with
a fresh 2% paraformaldehyde plus 0.2% glutaraldehyde in 0.1 M PBS. All
subsequent procedures, including washes, were performed with minimal
disruption of the pellets. Mitochondrial pellets were postfixed in 2% osmium
tetroxide in water for 2 h at 4 °C and followed by dehydration in a graded alcohol
series and embedded in Epon. Ultrathin sections (70 nm) were prepared with an
automatic ultramicrotome (Reichert Ultracut E) using a diamond knife. Sections
were collected on nickel grids (300 mesh) and double stained with 1% uranyl
acetate (1 h, room temperature) and 0.02% lead citrate (1min), and examined by a
transmission electron microscope (JEM2000 EXII, JEOL LTD, Tokyo, Japan).
2.5. Measurement of mitochondrial ATP content
Mitochondrial ATP content was determined by using an ATP determination
kit (Molecular Probes, Eugene, USA) with some modification, as described by
Drew and Leeuwenburgh [21]. ATP standards were prepared using known
concentrations of ATP (10, 20, 100, 200, 500 and 1000 μM, respectively). In the
beginning, the background of the reaction mixture (190 μl) was recorded using
an automatic luminometer (Lucy 1, Anthos Labtec Instruments, Salzburg,
Austria) before the mitochondria was added. The background value associated
with the reaction mixture could be subtracted. Then, 10 μ1 freshly isolated
mitochondria (1 μg) was added to the reaction mixture to detect the ATP content
immediately.
2.6. Estimation of ATP synthase activity by coupled enzyme assay
ATP synthase activity was measured by monitoring the increase in
absorbance at 340 nm using an NADP+ -linked, ADP-regenerating system, as
previously described [22]. Equal amount of fresh MgATP-SMPs (final protein
concentration was 0.1 mg/ml) was added to the reaction mixture containing
10 mM KPO4, 10 mM succinate, 50 mM Tris-acetate (pH 7.5), 1 mM glucose,
1 mM NADP+, 2 mMMgCl2, 2 mg/ml bovine albumin, 200 mM sucrose, 20 IU
hexokinase (Roche, Penzberg, Germany) and 0.25 IU glucose-6-P dehydrogen-
ase (Roche, Penzberg, Germany). The total volume in the cuvette was 1 ml. The
blank cuvette contained air. The reaction was assayed at 25 °C and started by the
addition of 1 mM ADP using a Hitachi U-2000 spectrophotometer (Ibaraki,
Japan) equipped with 340 nm filter.
2.7. Reconstitution of synthetic IF1 peptide with MgATP-SMPs
IF1 reconstitution was performed as described by Zanotti et al. [23].
MgATP-SMPs (0.3 mg/ml) was incubated in a reconstitution buffer (200 mM
sucrose, 10 mM Tris/Acetate pH 6.7, 1 mM EDTA, 6 mM MgCl2, and 1 mM
Mg-ATP) with 2.4 μM IF1 synthetic peptide containing the binding segment
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Then, the suspension was centrifuged at 100,000×g for 20 min and the
reconstituted particles were resuspended in reconstitution buffer. An equal
amount of protein was used to measure the ATP hydrolytic activity as described
in the following method.
2.8. Measurement of mitochondrial ATP hydrolytic activity by coupled
enzyme assay
The mitochondrial ATP hydrolytic activity was measured using a coupled
assay to follow the oxidation of NADH to NAD+ at 340 nm as described
by Zanotti et al. [23]. The MgATP-SMPs (final protein concentration was
0.1 mg/ml) was added to the reaction mixture containing 200 mM sucrose,
50 mM KCl, 5 mM MgCl2, 10 IU lactate dehydrogenase (Roche, Penzberg,
Germany), 4 IU pyruvate kinase (Roche, Penzberg, Germany), 1 mM
phosphoenolpyruvate, 0.1 mM NADH, 20 mM Tris/HCl, pH 7.4. The total
volume was 1 ml. The blank cuvette contained air. The reaction was started by
the addition of 1 mM ATP and run using a Hitachi U-2000 spectrophotometer
(Ibaraki, Japan) equipped with 340 nm filter. The linear reaction was followed
for 3 min at 340 nm and 25 °C.
2.9. RNA preparation and Northern blot analysis
Total RNAwas isolated from fresh liver tissue using TRIzol reagent (Mole-
cular Research Center Inc., Cincinnati, USA). For Northern blot analysis, the
RNA samples (25 μg/lane) were fractionated by electrophoresis on a 1% agarose
formaldehyde gel and transferred to N+-Hybond membrane (Amersham
Pharmacia Inc., New Territories, Hong Kong). Input loading was normalized
to 18S rRNA. The cDNA (5 μg) of IF1 was labeled with a [α-32P]-dCTP using a
High Prime reaction mix according to the manufacturer's instructions (Roche,
Mannheim, Germany). Hybridization was preformed at 68 °C overnight in hy-
bridization buffer (Clontect Laboratories, Inc., Palo Alto, USA). After hybri-
dization, the membrane was washed three times and then wrapped in a plastic
wrap to keep it from drying out and immediately exposed to film for auto-
radiography. Relative density of each band was measured by computer-assisted
densitometry and Bio-1D V.97 software (Vilber lourmat, France).
2.10. Western blot analysis
Equal amount of protein extract (5 μg/lane) were separated by 12% SDS-
PAGE (for individual IF1, CcO IV and GAPDH protein detection) or 8% SDS-
PAGE (for individual F1-ATPase α-, β-subunit protein detection), then trans-
ferred to polyvinylidene difluoride membranes (NEN Life Science Products,
Boston, USA). The membranes were blocked in TBS-t and supplemented with
5% nonfat dry milk powder on a shaker at 4 °C overnight. Then the membranes
were incubated with primary mouse IF1 (1:1000), F1-ATPase α-(1:1000)(Mole-
cular Probes, Eugene, USA) and β-subunit antibodies (1:1000) (Abcam Inc.,
Cambridge, UK) for 1 h at room temperature, respectively. After that, incubation
with goat antimouse secondary antibody conjugated with peroxidase (1:10,000
in TBS-t/5% milk) (Santa Cruz, California, USA) was performed for 1 h at room
temperature. Detection was by ECL (Pharmacia Biotech, Välinge, Sweden)
according to the manufacturer's instructions, and subsequently exposed to X-ray
film, respectively. Relative density of each band was measured by computer-
assisted densitometry and Bio-1D V.97 software (Vilber lourmat, France).
2.11. Immunoprecipitation
Immunoprecipitation was used to detect protein–protein interaction between
IF1 and F1-ATPase α- and β-subunit. For immunoprecipitation, 200 μg of
submitochondrial particles were mixed with 20 μg of F1-ATPase β-subunit
monoclonal antibody (Abcam Inc., Cambridge, UK) and incubated with gentle
rocking at 4 °C overnight. An equal amount of Protein A/G-agarose (Calbio-
chem, Darmstadt, Germany) was added and rocked for additional 1 h at 4 °C.
Precipitated complexes were centrifuged and washed four times in immunopre-
cipitation binding buffer [50mMTris-base, 150mMNaCl, 5 mMEDTA, pH 7.0,
0.1%NP-40, 1-fold protease-inhibitory-cocktail (Roche,Mannheim,Germany)],
and then boiled in 2-fold SDS-sample buffer for 5 min. The precipitated com-plexes were centrifuged again and then the fractions of the supernatant were
analyzed by 12% SDS-PAGE (for IF1 protein detection) or 8% SDS-PAGE (for
individual F1-ATPase α-, β-subunit protein detection), and then immunoblotted
with indicated antibodies. The subunits of the F1-ATPase were analyzed using
Coomassie Brilliant Blue R-250 staining. Because only immunoprecipitated
protein was added to each lane, no other proteins could be reliably detected on the
gels. Submitochondrial particles from sham-operation and late septic liver con-
taining identical amounts of proteins (as measured) were used for the immuno-
precipitation. It was important to confirm that these submitochondrial particles
were equivalent. To achieve that, we performed Western blotting of submito-
chondrial particles from sham-operation and late septic liver used for F1-ATPase
β-subunit immunoprecipitation. For this Western blotting, an anti-cytochrome c
oxidase subunit IV (CcO IV) antibody was used. This control, then, provided
evidence that equal amounts of CcO IV were present when a fixed amount of
submitochondrial particles (as measured) were sampled for F1-ATPaseβ-subunit
immunoprecipitation. Relative density of each band was measured by computer-
assisted densitometry and Bio-1D V.97 software (Vilber lourmat, France).
2.12. Statistical analysis
To obtain reaction rates, the linear range of the absorbance change with
respect to time was used for both ATP synthase and ATP hydrolytic activity. A
molar extinction coefficient of 6.22×103 M cm−1 was used for NADH to cal-
culate the activity in μmoles ATP hydrolyzed or synthesized per min per mg
protein. All data are expressed as mean±SD. Statistical analysis was performed
using Student's t test. A value of p<0.05 was considered significant difference.
3. Results
3.1. Ultrastructure abnormality of hepatic mitochondria in
late sepsis
The hepatic mitochondrial ultrastructure was observed by
transmission electron microscope. The quality of isolated
mitochondria from rat liver was pure according to our method
(Fig. 1A). In the sham-operated control group, the mitochondria
was smooth with distinct cristae and complete membranes (Fig.
1C). At 18 h after CLP induction, mitochondrial swelling was
accompanied by a disruption of outermembrane integrity and
disarrayed cristae (Fig. 1B, D). As observed previously [11],
these changes were typical of mitochondrial injury of liver
during sepsis.
3.2. Decrease of mitochondrial ATP content in septic liver
To determine mitochondrial dysfunction in late sepsis, intra-
mitochondrial ATP content and ATP synthase activity of com-
plex V were measured. The result showed that mitochondrial
ATP content decreased significantly in late septic liver (Fig.
2A). While, no significant difference of ATP synthesis activity
was observed between sham-operated and late septic livers
(Fig. 2B).
3.3. IF1 inhibited the activity of ATP hydrolase in
submitochondrial particles of septic liver
In order to elucidate the role of IF1 in inhibiting the activity
of mitochondrial ATP hydrolase during sepsis, the ATP hydro-
lysis of septic liver MgATP-SMPs was determined without or
with reconstitution with IF1-(Leu 42–Lys 58) synthetic peptide
(Fig. 3). The result showed that the ATP hydrolysis in MgATP-
Fig. 1. Representative electron photomicrographs of liver mitochondria obtained from sham-operated (A and C) and CLP-treated (B and D) animals at 18 h
posttreatment. The quality of isolated mitochondria from liver was pure (A). Compared with the normal structure of mitochondria in the sham animal (C), observe that
after CLP treatment, mitochondria demonstrated an increased extent of disarrayed cristae and loss of membrane integrity (D; black and white arrow, respectively).
Original magnification: (A) ×8000; (B) ×10,000; (C, D) ×50,000.
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112% after CLP. Whereas, reconstitution of MgATP-SMPs with
IF1 synthetic peptide reversed the increase of ATP hydrolysis
caused by septic condition. It implies that the elevated ATP
hydrolysis may contribute to the decrease of mitochondrial ATP
content under septic condition. Furthermore, loss of IF1 inhi-
bition on the ATP hydrolase activity of MgATP-SMPs from
septic liver may contribute to the decrease of ATP content du-
ring sepsis.
3.4. IF1 mRNA expression
In order to confirm the previous result from differential ex-
pressed genes after suppression subtractive hybridization
(SSH), steady state mRNA levels of IF1 in sham and late sep-
tic groups were compared by Northern blot analysis using 18Sas a loading control (Fig. 4). The result showed that the mRNA
expression of IF1 was significantly decreased by 46% in the late
septic liver compared to the sham-operated group (p<0.01).
3.5. Declination of IF1 protein content in mitochondria at late
sepsis
To investigate the precise level of IF1 in the mitochondria,
the cytosolic and mitochondrial fractions were isolated and the
purity of the two fractions was confirmed by cross-reacting with
monoclonal antibodies directed against GAPDH and cyto-
chrome c oxidase subunit IV. The results showed that GAPDH
and the cytochrome c oxidase subunit IV protein were highly
enriched in the cytosolic and mitochondrial fractions, respec-
tively (Fig. 5). The presence of IF1 protein was determined in
the mitochondria of both sham-operated and late septic livers.
Fig. 3. IF1 inhibited the activation of ATP hydrolase by septic insult.
Submitochondrial particles of rat liver were incubated with a reconstitution
mixture in the presence or absence of 2.4 μM IF1-(Leu 42–Lys 58) synthetic
peptide. The ATP hydrolase activity was assayed spectrophotometrically at
25 °C with 1 mM ATP in the ATP-regenerating pool, as described in Materials
and methods. The final protein concentration of MgATP-SMPs in cuvette was
0.1 mg/ml. Sham, sham-operated control group; LS, late septic group. Data were
expressed as mean±SD of 6 animals in each group. *p<0.05; **p<0.01.
Fig. 4. Decrease of mRNA level of IF1 in liver at 18 h after CLP. Expressions of
IF1 mRNA in the livers of sham and late septic rats were measured by Northern
blot analysis. A representative result is shown in the upper panel and quantitative
data are shown in the lower panel. 18S was used as a loading control. Data were
expressed as mean±SD of 4 animals in each group. Sham, sham-operated
control group; LS, late septic group. **Denotes significant difference (p<0.01)
from sham control.
Fig. 2. Decrease of ATP content but not ATP synthesis activity in septic liver at
18 h after cecal ligation and puncture (CLP). (A) Mitochondrial ATP content
was measured by bioluminescence assay based on the reaction of ATP with
recombinant firefly luciferase and its substrate luciferin. (B) The ATP synthesis
activity was assayed spectrophotometrically at 25 °C with 1 mM ADP in the
ADP-regenerating pool, as described inMaterials and methods. The final protein
concentration of MgATP-SMPs in cuvette was 0.1 mg/ml. Sham, sham-operated
control group; LS, late septic group. Data were expressed as mean±SD of 6
animals in each group. N.S. indicates non-significant difference. *Denotes
significant difference (p<0.05) from sham control.
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significantly decreased in the late septic condition by 57%
compared to the sham group (p<0.05). Cytochrome c oxidase
subunit IV (CcO IV) was used as a mitochondrial marker pro-
tein to normalize the levels of IF1. Under all treatment condi-
tions, CcO IV protein expression was unaltered. To investigate
the possible transporting of IF1, cytosolic and mitochondrial
fractions were detected usingWestern blot analysis. In the upper
panel of Fig. 5, it is shown, regardless of which fraction under-
went sepsis, that the IF1 was only present in the mitochondria
but not in the cytosolic fractions.
3.6. No change of α and β subunit proteins of F1-ATPase
during sepsis
To explore the role of subunit proteins of F1-ATPase contri-
buting to the mitochondrial dysfunction, the F1-ATPase α- or β-subunits were quantified by Western blot analysis. The re-
sults showed that neither α- nor β-subunit of F1-ATPase was
changed in the liver at late stage of sepsis (Fig. 6A and B).
3.7. Interaction of IF1 and F1-ATPase α/β subunit protein in
liver of late sepsis
For further understanding of the interaction of IF1 with F1-
ATPase under septic conditions, submitochondrial particles
were immunoprecipitated by using an antibody specific for F1-
Fig. 6. No significant changes of the mitochondrial F1-ATPase after CLP. (A) α-subu
and late septic liver tissues were extracted and immunoblotted with F1-ATPase α and
weights of F1-ATPase α- and β-subunit are 59.8 and 50 kDa, respectively. Data were e
group; LS, late septic group. N.S. represents no significant difference.
Fig. 5. Decrease of mitochondrial IF1 protein content in septic liver. Sham-
operation (Sham) and late septic liver (LS) were fractionated by sequential
centrifugation to generate fractions enriched in mitochondria and cytosol. Equal
amount of protein from each fraction were then separated by 12% and 8% SDS-
PAGE.Membraneswere incubatedwith antibodies against GAPDH, cytochrome
c oxidase subunit IV (CcO IV) and IF1, individually. GAPDH and CcO IV were
used as cytosolic and mitochondrial markers, respectively, to confirm the
isolation purity of two fractions. The protein content of IF1 was normalized by
CcO IV. The molecular weights (MW) of the standard proteins are shown in left
sites. Data were expressed as mean±SD of 6 animals in each group. *Denotes
significant difference (p<0.05) from sham control.
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was identified by Western blotting analysis using antibodies of
IF1 and α-, β-subunit proteins. Additionally, another Western
blotting of submitochondrial particles with antibody against
cytochrome c oxidase subunit IV (CcO IV) was performed,
which used as a loading control in immunoprecipitation study
(Fig. 7C). The subunit profile of F1F0 and other SMP proteins in
this immunoprecipitation procedure is shown in Fig. 7A. The α,
β, and δ subunits were individually detected as a single band
except γ and ε subunits.
The result showed that the association of IF1 with F1-
ATPase-β subunit was significantly decreased by 40.7% (p<
0.01) during late sepsis (Fig. 7B). Neither α- nor -β subunit of
precipitated F1-ATPase changed significantly in the septic liver.
4. Discussion
The most common cause of death in critical sepsis is the
dysfunction of multiple organs. Among the organ systems, he-
patic failure is usually thought to be a late complication follow-
ing pulmonary and renal failure in the cascade of sepsis [24].
The liver plays roles in four key areas of metabolism: fuel
management, nitrogen excretion, the regulation of water distri-
bution between the blood and tissues, and the detoxification of
foreign substances. Besides, it is a major organ of synthesis of
functional proteins, such as clotting factors, albumin. So far, the
study of underlying pathophysiology of the sepsis-induced
hepatic dysfunction is not conclusive. Many reports suggest that
mitochondrial dysfunction with a progressive energy deficiency
should be the reason for hepatic dysfunction [25,26]. Other
studies have also discovered that intramitochondrial production
of the hydroxyl radical results in local damage to lipid, DNA ornit of F1-ATPase, (B) β-subunit of F1-ATPase. Mitochondrial proteins of sham
β antibodies, respectively. CcO IV was used as a loading control. The molecular
xpressed as mean±SD of 6 animals in each group. Sham, sham-operated control
Fig. 7. Decrease in association of IF1 with F1-ATPase α- and β-subunit protein
after CLP. Submitochondrial particles of sham and late septic liver tissue were
immunoprecipitated with F1-ATPase β-subunit antibody and then analyzed by
12% SDS-PAGE, and visualized with Coomassie Brilliant Blue R-250 stain. The
α, β and δ subunits were individually detected as a single band expect γ subunit
(dashed lines) (A). Besides, membranes were immunoblotted with IF1,
F1-ATPase α and β antibodies, respectively (B). The amounts of CcO IV from
another Western blotting analysis were used as a loading control (C). The
quantitative data shown in the lower panel indicates mean±SD of 6 animals
in each group. Sham, sham-operated control group; LS, late septic group.
**Denotes significant difference (p<0.01) from sham control.
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thermore, disruption of mitochondrial membrane has been re-
ported to be an early and irreversible event leading to apoptosis,
which may be important in human sepsis with systemic organ
dysfunction [29]. From our previous and current studies, we
demonstrated ATP content declined significantly in both total
liver tissues and mitochondria. Besides, we also observed that
mitochondrial ultrastructure was obviously damaged. It is clearthat energy deficiency is present during sepsis that is highly
associated with mitochondrial dysfunction.
The mitochondrial respiratory chain is located in the inner
mitochondrial membrane and is composed of four individual
enzyme complexes (I to IV). Electrons derived from oxidation
of glucose or fatty acids are transferred through the complex I,
III, and IV to carry protons from the mitochondrial matrix to the
intermembrane space. An electrochemical proton gradient is
then generated, which is utilized by the fifth enzyme complex
(ATP synthase) to produce ATP from adenosine diphosphate
(ADP) and inorganic phosphate. In fact, a number of sepsis-
induced alterations in mitochondrial respiratory activity have
been described, including complex I, II, III, and IV [10–12].
However, there are few studies of the role of complex V in the
septic liver. ATP synthase consists of two main parts; a
hydrophilic F1-part carrying catalytic sites (F1-ATPase) and a
hydrophobic F0-part that is involved in proton translocation.
ATP synthase is responsible for the majority of ATP synthesis
(∼95% of energy needed) during normoxic conditions, but it is
prone to carry out ATP hydrolysis under an ischemic situation,
also termed as F0F1-ATPase.
Experimental evidence suggests that F0F1-ATPase is an im-
portant consumer of ATP during ischemia [12,14]. When oxy-
gen deprivation collapses the mitochondrial electrochemical
gradient, F0F1-ATPase subsequently switches from ATP synthe-
sis to ATP hydrolysis. Oligomycin, a non-selective F0F1-
ATPase inhibitor, is revealed to decrease the rate of ATP de-
pletion in globally ischemic dog heart ex vivo [14]. Other
studies further showed that the selective F0F1-ATPase hydrolase
inhibitor, BMS-199264, reduced ATP declination during ische-
mia and exerted significantly cardioprotective effects without
affecting ATP synthesis in normal or reperfused tissue [30]. It is
clear that an increase of F0F1-ATPase activity plays a role in
decreasing ATP concentration during certain pathological con-
ditions. The current study obviously showed that the mitochon-
drial F0F1-ATPase activity is notably elevated in late septic
liver, while the synthetic activity of ATP is not different bet-
ween sham-operated and late septic rats. Eventually, the intra-
mitochondrial ATP concentration reduced significantly in late
septic liver. These results indicate that mitochondrial F0F1-
ATPase participates in hepatic energy insufficiency in sepsis.
The activity of the proton-pumping F0F1-ATPase is regulated
in vivo by different specific regulatory elements, such as ADP, a
proton motive force (ΔμH+) generated by electrochemical gra-
dient and IF1 inhibitor protein [31]. Among them, the IF1 plays
a prominent role. IF1 was first isolated by Pullman and Monroy
in 1963 as a powerful inhibitor of hydrolysis, and binds to F0F1-
ATPase in a 1:1 stoichiometry [32]. Studies from Yamada and
Huzel [33] showed that IF1 activity could not be measured in
the GM28 fibroblasts cultured from the skeletal muscle of the
patients of Luft's disease, a rare human mitochondrial myo-
pathy. Besides, Banerjee et al. made the important observation
that inhibition of F0F1-ATPase and preservation of ATP is de-
pendent on the concentration of IF1 under paracetamol-induced
hepatotoxicity in rats [34]. Accordingly, we assume that the IF1
expression is probably a crucial factor in modulating the F0F1-
ATPase activity during septic conditions. In our result, it ob-
895L.-J. Huang et al. / Biochimica et Biophysica Acta 1767 (2007) 888–896viously revealed the addition of IF1-(Leu 42–Lys 58) synthetic
peptide exerted a marked inhibitory effect on the rate of ATP
hydrolysis in MgATP-SMPs of late septic liver. This result
reflects the expression failure of IF1 might highly correlate with
the elevated F0F1-ATPase activity in the liver of late sepsis. As
expected, the key finding of this study showed that the mRNA
as well as the mitochondrial protein content of IF1 decreased
significantly pending late sepsis.
IF1 gene is a nuclear gene and the presequence is required for
transport into the mitochondria [35]. Several reports have
shown that IF1 binds at the β-subunit of the enzyme or at the
interface between α- and β-subunits of F0F1-ATPase [36,37],
and also in close proximity of the rotor subunits γ and ε [38],
thus blocking catalytic conformational changes and rotation of
the central stalk to inhibit futile ATP hydrolysis. In this study,
we observed that there is no detectable IF1 protein in the
cytosolic fraction regardless of sham or septic group. It implies
that sepsis-associated declination of IF1 in the mitochondria is
not due to the transporting failure. We further observed the
association activity of mitochondrial IF1 with β-subunit
significantly decreased in late sepsis, while the protein level
of α- and β-subunits is not altered. However, compared with
the IF1 content in the mitochondria and immunoprecipitated
F1-ATPase complex, it seems reasonable to conclude that the
association activity of IF1 protein is not affected. Therefore,
downregulation of IF1 expression seems to be the key
mechanism in energy deficiency of septic liver.
In conclusion, we suggest for the first time that the suppres-
sion of IF1 expression and subsequent elevated mitochondrial
F0F1-ATPase activity might contribute to the bioenergetic fail-
ure in the liver during late sepsis. It is important to point out that
the opposite effect of IF1 has been demonstrated during its
overexpression in rat hepatoma as compared to rat liver. When
IF1 is 2-fold overexpressed in hepatoma mitochondria, it is
associated more efficiently with the mitochondrial ATP syn-
thase, thus reducing the futile hydrolysis of mitochondrial and
glycolytic ATP [39]. In summary, it seems that down-regulation
or over-expression of IF1 controls the ATP content of cells in an
opposite fashion and according to cellular ATP requirements.
We hope that this novel result might highlight an original
therapeutic aspect of energy preservation in managing sepsis.
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